Email this article 
The use of Kuraderm drug in the treatment of basal cell carcinoma of the head and neck
- Authors: Dobrokhotova V.Z.1, Batsev A.F.2, Belysheva T.S.2
-
Affiliations:
- Department of Urology of the Sechenov First Moscow State Medical University
- N.N. Blokhin Russian Cancer Research Center, Ministry ofHealth of Russia
- Issue: Vol 6, No 3 (2016)
- Pages: 22-26
- Section: DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS
- Published: 21.10.2016
- URL: https://ogsh.abvpress.ru/jour/article/view/218
- DOI: https://doi.org/10.17650/2222-1468-2016-6-3-22-26
- ID: 218
Cite item
Full Text
Abstract
Basal cell carcinoma is one of the most common malignancies. Despite a wide range of treatment options and relatively good prognosis of the disease, there may be restrictions on the use of standard methods of treatment because of elderly patients, their physical condition and characteristics of the tumor localization. We provide clinical examples of successful treatment of basal cell carcinoma of the head and neck with Kuraderm BEC5. This is a drug with anti-tumor activity for topical use made on the basis of glycoalkaloids of plants of nightshade family.
About the authors
V. Z. Dobrokhotova
Department of Urology of the Sechenov First Moscow State Medical University
Email: fake@neicon.ru
8 Trubetskaya St., Moscow, 119991 Russian Federation
A. F. Batsev
N.N. Blokhin Russian Cancer Research Center, Ministry ofHealth of Russia
Author for correspondence.
Email: batsevhph@mail.ru
24 Kashirskoe Shosse, Moscow, 115478 Russian Federation
T. S. Belysheva
N.N. Blokhin Russian Cancer Research Center, Ministry ofHealth of Russia
Email: fake@neicon.ru
24 Kashirskoe Shosse, Moscow, 115478 Russian Federation
References
Supplementary files
